Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation.
Antunes HS, Herchenhorn D, Small IA, Araújo CM, Viégas CM, Cabral E, Rampini MP, Rodrigues PC, Silva TG, Ferreira EM, Dias FL, Ferreira CG. Antunes HS, et al. Among authors: herchenhorn d. Radiother Oncol. 2013 Nov;109(2):297-302. doi: 10.1016/j.radonc.2013.08.010. Epub 2013 Sep 14. Radiother Oncol. 2013. PMID: 24044799 Clinical Trial.
The Impact of Fibroblast Growth Factor Receptor Alterations in Clinical Outcomes of Patients With Advanced Urothelial Carcinoma: Real-World Data From a Latin American Population.
Souza VC, Monteiro FSM, Maluf FC, Werutsky G, Fabrício VC, Gidekel R, Gandur-Quiroga MN, Freitas MRP, Luz M, Campos-Gomez S, Junior JAR, Bastos DA, Sade JP, da Trindade KM, Mota ACA, Fernandes RC, Ruíz AOB, Pereira E Silva BD, de Oliveira FNG, Cutuli HJ, Nogueira L, Aceituno LFG, Fernandez M, Inman E, Caitano M, Herchenhorn D, Ardila-Salcedo J, Pacheco P, de Jesus RG, Gössling G, Soares A, Fay AP. Souza VC, et al. Among authors: herchenhorn d. Clin Genitourin Cancer. 2024 Oct;22(5):102174. doi: 10.1016/j.clgc.2024.102174. Epub 2024 Jul 25. Clin Genitourin Cancer. 2024. PMID: 39181783
Characterization of Wnt Signaling Pathway Aberrations in Metastatic Prostate Cancer.
Choi SH, Pan E, Elliott A, Beltran H, Panian J, Jamieson C, Bagrodia A, Rose B, Herchenhorn D, Heath E, Nabhan C, Antonarakis ES, McKay RR. Choi SH, et al. Among authors: herchenhorn d. Mol Cancer Res. 2024 Oct 2;22(10):920-931. doi: 10.1158/1541-7786.MCR-24-0395. Mol Cancer Res. 2024. PMID: 38912907
Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update.
Soares A, Monteiro FSM, da Trindade KM, Silva AGE, Cardoso APG, Sasse AD, Fay AP, Carneiro APCD, Alencar Junior AM, de Andrade Mota AC, Santucci B, da Motta Girardi D, Herchenhorn D, Araújo DV, Jardim DL, Bastos DA, Rosa DR, Schutz FA, Kater FR, da Silva Marinho F, Maluf FC, de Oliveira FNG, Vidigal F, Morbeck IAP, Rinck Júnior JA, Costa LAGA, Maia MCDF, Zereu M, Freitas MRP, Dias MSF, Tariki MS, Muniz P, Beato PMM, Lages PSM, Velho PI, de Carvalho RS, Mariano RC, de Araújo Cavallero SR, Oliveira TM, Souza VC, Smaletz O, de Cássio Zequi S. Soares A, et al. Among authors: herchenhorn d. J Cancer Res Clin Oncol. 2024 Apr 9;150(4):183. doi: 10.1007/s00432-024-05663-z. J Cancer Res Clin Oncol. 2024. PMID: 38594593 Free PMC article. Review.
XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapy.
Pinho MB, Costas F, Sellos J, Dienstmann R, Andrade PB, Herchenhorn D, Peixoto FA, Santos VO, Small IA, Guimarães DP, Ferreira CG. Pinho MB, et al. Among authors: herchenhorn d. Urol Oncol. 2009 Jul-Aug;27(4):382-90. doi: 10.1016/j.urolonc.2008.03.016. Epub 2008 Jun 16. Urol Oncol. 2009. PMID: 18555708 Clinical Trial.
Phase I trial of erlotinib combined with cisplatin and radiotherapy for patients with locally advanced cervical squamous cell cancer.
Nogueira-Rodrigues A, do Carmo CC, Viegas C, Erlich F, Camisão C, Fontão K, Lima R, Herchenhorn D, Martins RG, Moralez GM, Small IA, Ferreira CG. Nogueira-Rodrigues A, et al. Among authors: herchenhorn d. Clin Cancer Res. 2008 Oct 1;14(19):6324-9. doi: 10.1158/1078-0432.CCR-07-5112. Clin Cancer Res. 2008. PMID: 18829516 Clinical Trial.
Phase I/II study of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck.
Herchenhorn D, Dias FL, Viegas CM, Federico MH, Araújo CM, Small I, Bezerra M, Fontão K, Knust RE, Ferreira CG, Martins RG. Herchenhorn D, et al. Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):696-702. doi: 10.1016/j.ijrobp.2009.08.079. Epub 2010 Apr 24. Int J Radiat Oncol Biol Phys. 2010. PMID: 20421154 Clinical Trial.
42 results